Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters

[1]  M. Isalan,et al.  Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings , 2022, Frontiers in Medicine.

[2]  J. Flannery,et al.  Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness , 2021, bioRxiv.

[3]  K. Xue,et al.  Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina , 2021, Molecular therapy. Methods & clinical development.

[4]  R. MacLaren,et al.  An analysis of the Kozak consensus in retinal genes and its relevance to gene therapy , 2021, Molecular vision.

[5]  P. Yu-Wai-Man,et al.  Humoral immune responses to AAV gene therapy in the ocular compartment , 2021, Biological reviews of the Cambridge Philosophical Society.

[6]  K. Martin,et al.  Receptor-ligand supplementation via a self-cleaving 2A peptide–based gene therapy promotes CNS axonal transport with functional recovery , 2021, Science Advances.

[7]  Rachelle A. Farkas,et al.  Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells , 2021, Gene Therapy.

[8]  Johannes C. M. van der Loo,et al.  The clinical landscape for AAV gene therapies , 2021, Nature Reviews Drug Discovery.

[9]  J. Sahel,et al.  Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset. , 2021, Ophthalmology.

[10]  S. Boye,et al.  Current Clinical Applications of In Vivo Gene Therapy with AAVs , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  David J. Calkins,et al.  Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy , 2020, Science Translational Medicine.

[12]  James R. Tribble,et al.  Protrudin functions from the endoplasmic reticulum to support axon regeneration in the adult CNS , 2020, Nature Communications.

[13]  Livia S. Carvalho,et al.  Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration , 2020, BioDrugs.

[14]  James R. Tribble,et al.  Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction , 2020, bioRxiv.

[15]  P. Humphries,et al.  Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells , 2020, Scientific Reports.

[16]  Melissa R. Andrews.  Gene therapy in the CNS—one size does not fit all , 2020, Gene Therapy.

[17]  Bart Nieuwenhuis Department of Computing,et al.  Simple RGC: ImageJ Plugins for Counting Retinal Ganglion Cells and Determining the Transduction Efficiency of Viral Vectors in Retinal Wholemounts , 2020, 2008.06276.

[18]  J. Fawcett,et al.  Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters , 2020, Gene Therapy.

[19]  B. Roska,et al.  Restoring light sensitivity using tunable near-infrared sensors , 2020, Science.

[20]  J. Wijnholds,et al.  Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays , 2020, International journal of molecular sciences.

[21]  Hannah C. Webber,et al.  Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells , 2020, The Journal of Neuroscience.

[22]  D. Priestman,et al.  Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes , 2020, Human molecular genetics.

[23]  F. Mingozzi,et al.  AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  Charles M. Lieber,et al.  Single-Cell Profiles of Retinal Ganglion Cells Differing in Resilience to Injury Reveal Neuroprotective Genes , 2019, Neuron.

[25]  S. Siniossoglou,et al.  Rewiring Neuronal Glycerolipid Metabolism Determines the Extent of Axon Regeneration , 2019, Neuron.

[26]  J. Fawcett,et al.  PI 3‐kinase delta enhances axonal PIP 3 to support axon regeneration in the adult CNS , 2019, bioRxiv.

[27]  D. Fischer,et al.  GSK3-CRMP2 signaling mediates axonal regeneration induced by Pten knockout , 2019, Communications Biology.

[28]  S. Hattar,et al.  Thrombospondin-1 Mediates Axon Regeneration in Retinal Ganglion Cells , 2019, Neuron.

[29]  Zhigang He,et al.  Elevating Growth Factor Responsiveness and Axon Regeneration by Modulating Presynaptic Inputs , 2019, Neuron.

[30]  F. Ducongé,et al.  Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain , 2019, Molecular therapy. Methods & clinical development.

[31]  G. Ming,et al.  Knocking Out Non-muscle Myosin II in Retinal Ganglion Cells Promotes Long-Distance Optic Nerve Regeneration , 2019, bioRxiv.

[32]  Rachelle A. Farkas,et al.  New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina , 2019, Human gene therapy.

[33]  Keerang Park,et al.  Adeno-Associated Viral Vector 2 and 9 Transduction Is Enhanced in Streptozotocin-Induced Diabetic Mouse Retina , 2018, Molecular therapy. Methods & clinical development.

[34]  Aiman S Saab,et al.  Intravitreal AAV-Delivery of Genetically Encoded Sensors Enabling Simultaneous Two-Photon Imaging and Electrophysiology of Optic Nerve Axons , 2018, Front. Cell. Neurosci..

[35]  F. Esposti,et al.  Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans , 2018, Nature Neuroscience.

[36]  K. Martin,et al.  Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling , 2018, Cell Death & Disease.

[37]  I. Constable,et al.  Surgical Removal of Internal Limiting Membrane and Layering of AAV Vector on the Retina Under Air Enhances Gene Transfection in a Nonhuman Primate. , 2018, Investigative ophthalmology & visual science.

[38]  K. Martin,et al.  Design of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons , 2018, Human gene therapy.

[39]  J. Caprioli,et al.  RNA-binding protein Rbpms is represented in human retinas by isoforms A and C and its transcriptional regulation involves Sp1-binding site , 2018, Molecular Genetics and Genomics.

[40]  Serge Picaud,et al.  Noninvasive gene delivery to foveal cones for vision restoration. , 2018, JCI insight.

[41]  B. Chauhan,et al.  In vivo imaging of adeno-associated viral vector labelled retinal ganglion cells , 2018, Scientific Reports.

[42]  C. L. Schlamp,et al.  AAV2-Mediated Transduction of the Mouse Retina After Optic Nerve Injury , 2017, Investigative ophthalmology & visual science.

[43]  J. Flannery,et al.  Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina , 2017, Gene Therapy.

[44]  Philippe Hantraye,et al.  A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[45]  K. Martin,et al.  Neuroprotective Effects of Human Mesenchymal Stem Cells and Platelet‐Derived Growth Factor on Human Retinal Ganglion Cells , 2017, Stem cells.

[46]  Alfonso Blanco Fernández,et al.  A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors , 2017, Front. Neurosci..

[47]  Paul D. Gamlin,et al.  Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  M. S. Chapman,et al.  Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor , 2017, Journal of Virology.

[49]  T. Nakazawa,et al.  Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury , 2017, Molecular therapy. Methods & clinical development.

[50]  L. Vandenberghe,et al.  Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection , 2017, Scientific Reports.

[51]  Pete A. Williams,et al.  Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice , 2017, Science.

[52]  R. MacLaren,et al.  Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina , 2016, Molecular therapy. Nucleic acids.

[53]  A. Harvey,et al.  Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF , 2016, Molecular therapy. Methods & clinical development.

[54]  Benjamin E. Deverman,et al.  Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B , 2016, Front. Mol. Neurosci..

[55]  D. Fischer,et al.  Boosting Central Nervous System Axon Regeneration by Circumventing Limitations of Natural Cytokine Signaling. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[56]  Olivier Marre,et al.  Red‐shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina , 2016, EMBO molecular medicine.

[57]  M. Michaelides,et al.  Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65 , 2016, Gene Therapy.

[58]  H. Liang,et al.  Promoter methylation and histone modifications affect the expression of the exogenous DsRed gene in transgenic goats. , 2016, Genetics and molecular research : GMR.

[59]  R. Samulski,et al.  Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism , 2016, Journal of Virology.

[60]  C. von Kalle,et al.  Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain , 2016, Scientific Reports.

[61]  Steven J. M. Jones,et al.  rAAV-compatible MiniPromoters for restricted expression in the brain and eye , 2016, Molecular Brain.

[62]  Z. Pan,et al.  AAV-Mediated Transduction and Targeting of Retinal Bipolar Cells with Improved mGluR6 Promoters in Rodents and Primates , 2016, Gene Therapy.

[63]  W. Feuer,et al.  Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results. , 2016, Ophthalmology.

[64]  S. Boye,et al.  Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors , 2016, Journal of Virology.

[65]  Yifeng Zhang,et al.  Promoting axon regeneration in the adult CNS by modulation of the melanopsin/GPCR signaling , 2016, Proceedings of the National Academy of Sciences.

[66]  D. Broadway,et al.  Human organotypic retinal cultures (HORCs) as a chronic experimental model for investigation of retinal ganglion cell degeneration. , 2016, Experimental eye research.

[67]  J. Grieger,et al.  Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[68]  J. Sanes,et al.  Restoration of Visual Function by Enhancing Conduction in Regenerated Axons , 2016, Cell.

[69]  M. S. Chapman,et al.  An essential receptor for adeno-associated virus infection , 2015, Nature.

[70]  Corrigendum , 2015, Global change biology.

[71]  E. Simpson,et al.  Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. , 2015, Human molecular genetics.

[72]  Oliver C. Turner,et al.  AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice , 2015, Molecular therapy. Methods & clinical development.

[73]  T. Yamamori,et al.  Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex , 2015, Neurosciences research.

[74]  J. Flannery,et al.  Gene therapy into photoreceptors and Müller glial cells restores retinal structure and function in CRB1 retinitis pigmentosa mouse models. , 2015, Human molecular genetics.

[75]  John G. Flannery,et al.  Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells , 2014, Proceedings of the National Academy of Sciences.

[76]  M. Selzer,et al.  The mTORC1 Effectors S6K1 and 4E-BP Play Different Roles in CNS Axon Regeneration , 2014, Nature Communications.

[77]  O. Isacson,et al.  Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection , 2014, Neuroscience Letters.

[78]  W. Hauswirth,et al.  Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs , 2014, Gene Therapy.

[79]  W. Hauswirth,et al.  Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. , 2014, JAMA ophthalmology.

[80]  N. Brecha,et al.  Melanopsin Ganglion Cells Are the Most Resistant Retinal Ganglion Cell Type to Axonal Injury in the Rat Retina , 2014, PloS one.

[81]  J. Verhaagen,et al.  A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons , 2013, Gene Therapy.

[82]  Chun-li Zhang,et al.  Crosstalk between KLF4 and STAT3 regulates axon regeneration , 2013, Nature Communications.

[83]  K. Park,et al.  Three-dimensional evaluation of retinal ganglion cell axon regeneration and pathfinding in whole mouse tissue after injury , 2013, Experimental Neurology.

[84]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[85]  Donald Robertson,et al.  Long-Term Gene Therapy Causes Transgene-Specific Changes in the Morphology of Regenerating Retinal Ganglion Cells , 2012, PloS one.

[86]  Dirk Trauner,et al.  LiGluR restores visual responses in rodent models of inherited blindness. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[87]  David R Williams,et al.  Intravitreal injection of AAV2 transduces macaque inner retina. , 2011, Investigative ophthalmology & visual science.

[88]  M. Ehlers,et al.  Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. , 2011, Human gene therapy.

[89]  Rafael J. Yáñez-Muñoz,et al.  Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector , 2011, Gene Therapy.

[90]  T. Huang,et al.  Targeted methylation of CMV and E1A viral promoters. , 2010, Biochemical and biophysical research communications.

[91]  Zhuo-Hua Pan,et al.  Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina. , 2010, Investigative ophthalmology & visual science.

[92]  N. Tanimoto,et al.  Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[93]  J. Wijnholds,et al.  GFAP-Driven GFP Expression in Activated Mouse Müller Glial Cells Aligning Retinal Blood Vessels Following Intravitreal Injection of AAV2/6 Vectors , 2010, PloS one.

[94]  Deniz Dalkara,et al.  Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[95]  A. Harvey,et al.  Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection , 2009, Gene Therapy.

[96]  Zhigang He,et al.  Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway , 2008, Science.

[97]  J. Bennett,et al.  Novel AAV serotypes for improved ocular gene transfer , 2008, The journal of gene medicine.

[98]  W. Hauswirth,et al.  Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: Effects of serotype and site of administration , 2008, Vision Research.

[99]  KouichiC . Nakamura,et al.  Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters , 2007, Gene Therapy.

[100]  E. Pugh,et al.  Fluorescence relaxation in 3D from diffraction‐limited sources of PAGFP or sinks of EGFP created by multiphoton photoconversion , 2007, Journal of microscopy.

[101]  Muna I. Naash,et al.  Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles , 2006, PloS one.

[102]  M. Kay,et al.  The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9 , 2006, Journal of Virology.

[103]  W. Hauswirth,et al.  Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[104]  W. Hauswirth,et al.  Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[105]  Y. Péréon,et al.  Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates. , 2005, Archives of ophthalmology.

[106]  K. Iwabuchi,et al.  Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection , 2005, Journal of Virology.

[107]  J. Kleinschmidt,et al.  Identification of a Heparin-Binding Motif on Adeno-Associated Virus Type 2 Capsids , 2003, Journal of Virology.

[108]  Donald J Zack,et al.  Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. , 2003, Investigative ophthalmology & visual science.

[109]  S. Kügler,et al.  Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. , 2003, Virology.

[110]  N. Muzyczka,et al.  Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding , 2003, Journal of Virology.

[111]  M. Moore,et al.  A quantitative analysis of intron effects on mammalian gene expression. , 2003, RNA.

[112]  S. Kügler,et al.  Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area , 2003, Gene Therapy.

[113]  A. R. Harvey,et al.  Intravitreal Injection of Adeno-associated Viral Vectors Results in the Transduction of Different Types of Retinal Neurons in Neonatal and Adult Rats: A Comparison with Lentiviral Vectors , 2002, Molecular and Cellular Neuroscience.

[114]  V. Perry,et al.  Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene , 2001, Nature Neuroscience.

[115]  L. Braiterman,et al.  Synapsin I is expressed in epithelial cells: localization to a unique trans-Golgi compartment. , 2001, Journal of cell science.

[116]  R. Haberman,et al.  Novel Transcriptional Regulatory Signals in the Adeno-Associated Virus Terminal Repeat A/D Junction Element , 2000, Journal of Virology.

[117]  J. Feldon,et al.  Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain , 2000, Gene Therapy.

[118]  M. Weitzman,et al.  Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. , 1999, Human gene therapy.

[119]  M. King,et al.  Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors , 1998, Experimental Neurology.

[120]  R. Samulski,et al.  Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.

[121]  A. Verkman,et al.  Photobleaching recovery and anisotropy decay of green fluorescent protein GFP-S65T in solution and cells: cytoplasmic viscosity probed by green fluorescent protein translational and rotational diffusion. , 1997, Biophysical journal.

[122]  P. Fan,et al.  Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. , 1996, Human gene therapy.

[123]  G. Breese,et al.  Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector , 1996, Brain Research.

[124]  H. Volk,et al.  Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro. , 1996, Biological chemistry Hoppe-Seyler.

[125]  M. Drumm,et al.  Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. , 1993, The Journal of biological chemistry.

[126]  M. Kozak,et al.  A short leader sequence impairs the fidelity of initiation by eukaryotic ribosomes. , 1991, Gene expression.

[127]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[128]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[129]  M. Kozak,et al.  Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo , 1984, Nature.

[130]  M. Kozak.  Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. , 1981, Nucleic acids research.

[131]  A. Harvey,et al.  Small Scale Production of Recombinant Adeno-Associated Viral Vectors for Gene Delivery to the Nervous System. , 2018, Methods in molecular biology.

[132]  M. Kay,et al.  A 5' Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from Recombinant AAV Vectors in vivo. , 2017, Human gene therapy.

[133]  Zhijian Wu,et al.  Effect of genome size on AAV vector packaging. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[134]  Keyun Qing,et al.  Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 , 1999, Nature Medicine.

[135]  R. Samulski,et al.  αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection , 1999, Nature Medicine.

[136]  R. Samulski,et al.  AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. , 1999, Nature medicine.

[137]  D. Housman,et al.  Corrigendum: Targeted integration of adeno-associated virus (AAV) into human chromosome 19 (The EMBO Journal (1991) 10 (3941-3950)) , 1992 .